Sirtris Pharmaceuticals
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.
Employees
Enterprise value
$720m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$720m Valuation: $720m | Acquisition | ||
| Total Funding | 000k | ||
Sanofi-Genzyme BioVentures(exited)
Bessemer Venture Partners(exited)
Black River Asset Management(exited)
Polaris Partners(exited)
Three Arch Partners(exited)
Skyline Ventures(exited)
Cardinal Partners(exited)
Wellcome Trust(exited)
Sanofi Ventures(exited)
Red Abbey Venture Partners(exited)
Cargill(exited)
TVM Capital Life Science(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads